Citigroup’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.4M | Sell |
1,047,000
-473,900
| -31% | -$12.6M | 0.01% | 882 |
|
|
2025
Q4 | $37.9M | Buy |
1,520,900
+708,900
| +87% | +$17.9M | 0.02% | 754 |
|
|
2025
Q3 | $20.7M | Sell |
812,000
-119,600
| -13% | -$2.95M | 0.01% | 1043 |
|
|
2025
Q2 | $22.6M | Sell |
931,600
-806,800
| -46% | -$18.8M | 0.01% | 904 |
|
|
2025
Q1 | $44.1M | Buy |
1,738,400
+63,300
| +4% | +$1.66M | 0.02% | 592 |
|
|
2024
Q4 | $44.4M | Buy |
1,675,100
+214,100
| +15% | +$5.81M | 0.03% | 570 |
|
|
2024
Q3 | $42.3M | Buy |
1,461,000
+367,500
| +34% | +$10.7M | 0.02% | 608 |
|
|
2024
Q2 | $30.6M | Sell |
1,093,500
-107,400
| -9% | -$2.96M | 0.02% | 705 |
|
|
2024
Q1 | $33.3M | Sell |
1,200,900
-419,500
| -26% | -$11.6M | 0.02% | 658 |
|
|
2023
Q4 | $46.7M | Buy |
1,620,400
+901,900
| +126% | +$27.3M | 0.03% | 487 |
|
|
2023
Q3 | $23.8M | Sell |
718,500
-504,300
| -41% | -$17.8M | 0.02% | 703 |
|
|
2023
Q2 | $44.9M | Sell |
1,222,800
-1,984,800
| -62% | -$77.3M | 0.03% | 480 |
|
|
2023
Q1 | $131M | Buy |
3,207,600
+1,798,000
| +128% | +$77.7M | 0.09% | 175 |
|
|
2022
Q4 | $72.2M | Buy |
1,409,600
+744,000
| +112% | +$35.7M | 0.06% | 306 |
|
|
2022
Q3 | $29.1M | Sell |
665,600
-186,800
| -22% | -$9.08M | 0.02% | 602 |
|
|
2022
Q2 | $44.7M | Buy |
852,400
+360,700
| +73% | +$18.4M | 0.03% | 417 |
|
|
2022
Q1 | $25.5M | Sell |
491,700
-1,549,400
| -76% | -$80.4M | 0.02% | 818 |
|
|
2021
Q4 | $121M | Buy |
2,041,100
+753,100
| +58% | +$37.3M | 0.06% | 268 |
|
|
2021
Q3 | $55.4M | Buy |
1,288,000
+649,800
| +102% | +$28.8M | 0.03% | 484 |
|
|
2021
Q2 | $25M | Sell |
638,200
-220,500
| -26% | -$8.57M | 0.02% | 878 |
|
|
2021
Q1 | $31.1M | Sell |
858,700
-1,523,900
| -64% | -$54.1M | 0.02% | 709 |
|
|
2020
Q4 | $87.7M | Sell |
2,382,600
-414,084
| -15% | -$15.2M | 0.05% | 314 |
|
|
2020
Q3 | $97.4M | Buy |
2,796,684
+1,109,019
| +66% | +$38.9M | 0.06% | 249 |
|
|
2020
Q2 | $52.4M | Sell |
1,687,665
-434,986
| -20% | -$14.8M | 0.04% | 381 |
|
|
2020
Q1 | $65.7M | Buy |
2,122,651
+615,536
| +41% | +$21M | 0.06% | 277 |
|
|
2019
Q4 | $56M | Buy |
1,507,115
+423,392
| +39% | +$15.1M | 0.04% | 454 |
|
|
2019
Q3 | $36.9M | Buy |
1,083,723
+288,480
| +36% | +$10.5M | 0.03% | 581 |
|
|
2019
Q2 | $32.7M | Sell |
795,243
-728,525
| -48% | -$28.9M | 0.03% | 640 |
|
|
2019
Q1 | $61.4M | Sell |
1,523,768
-1,135,263
| -43% | -$45.5M | 0.06% | 325 |
|
|
2018
Q4 | $110M | Buy |
2,659,031
+526,789
| +25% | +$21.9M | 0.11% | 164 |
|
|
2018
Q3 | $89.2M | Sell |
2,132,242
-1,183,115
| -36% | -$45.5M | 0.08% | 216 |
|
|
2018
Q2 | $114M | Buy |
3,315,357
+2,702,140
| +441% | +$92.3M | 0.1% | 155 |
|
|
2018
Q1 | $20.6M | Sell |
613,217
-1,297,790
| -68% | -$44.6M | 0.02% | 761 |
|
|
2017
Q4 | $65.7M | Sell |
1,911,007
-191,618
| -9% | -$6.53M | 0.05% | 342 |
|
|
2017
Q3 | $71.2M | Sell |
2,102,625
-41,843
| -2% | -$1.34M | 0.06% | 285 |
|
|
2017
Q2 | $68.3M | Sell |
2,144,468
-18,368,796
| -90% | -$579M | 0.06% | 252 |
|
|
2017
Q1 | $666M | Buy |
20,513,264
+17,813,232
| +660% | +$562M | 0.59% | 12 |
|
|
2016
Q4 | $83.2M | Sell |
2,700,032
-49,538
| -2% | -$1.51M | 0.08% | 251 |
|
|
2016
Q3 | $88.4M | Buy |
2,749,570
+141,658
| +5% | +$4.74M | 0.08% | 216 |
|
|
2016
Q2 | $87.1M | Sell |
2,607,912
-2,323,438
| -47% | -$74.2M | 0.09% | 208 |
|
|
2016
Q1 | $139M | Buy |
4,931,350
+322,208
| +7% | +$9.2M | 0.16% | 101 |
|
|
2015
Q4 | $141M | Sell |
4,609,142
-4,103,960
| -47% | -$129M | 0.14% | 119 |
|
|
2015
Q3 | $260M | Buy |
8,713,102
+5,582,617
| +178% | +$179M | 0.24% | 46 |
|
|
2015
Q2 | $99.6M | Buy |
3,130,485
+1,923,550
| +159% | +$62.7M | 0.09% | 204 |
|
|
2015
Q1 | $39.8M | Sell |
1,206,935
-1,555,704
| -56% | -$49.5M | 0.04% | 438 |
|
|
2014
Q4 | $81.6M | Buy |
2,762,639
+54,491
| +2% | +$1.56M | 0.07% | 270 |
|
|
2014
Q3 | $76M | Sell |
2,708,148
-161,683
| -6% | -$4.54M | 0.07% | 263 |
|
|
2014
Q2 | $80.8M | Buy |
2,869,831
+1,516,390
| +112% | +$43.2M | 0.08% | 244 |
|
|
2014
Q1 | $41.2M | Sell |
1,353,441
-1,746,162
| -56% | -$52.1M | 0.04% | 397 |
|
|
2013
Q4 | $90.1M | Buy |
3,099,603
+92,857
| +3% | +$2.7M | 0.08% | 221 |
|
|
2013
Q3 | $81.9M | Sell |
3,006,746
-1,555,282
| -34% | -$42.3M | 0.08% | 234 |
|
|
2013
Q2 | $121M | Buy |
+4,562,028
| New | +$126M | 0.12% | 117 |
|
Other funds holding PFE
VCM
VPM
Citigroup's PFE Position: Q1 2026 in Review
Citigroup increased its Pfizer (PFE) stake by 8.6% in Q1 2026, buying an estimated $32.7M and bringing the position to 15,493,259 shares worth $435M. The position accounts for 0.19% of the portfolio, ranked #98.
Citigroup first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Citigroup held 15,493,259 shares of Pfizer worth $435M as of Q1 2026.
- Citigroup bought 1,228,140 Pfizer shares in Q1 2026, an estimated $32.7M.
- Pfizer made up 0.19% of Citigroup's portfolio in Q1 2026, its #98 holding.
- Citigroup first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.